Press Releases

Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will...

Codiak BioSciences, a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines...

The Blood Profiling Atlas in Cancer Consortium (BloodPAC) published “Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group,” in the September 2020 issue of Clinical Chemistry. Developed by consortium members, the ...

Mursla, a liquid biopsy company, has raised £410K from the UK Government’s Future Fund and existing investors. In addition, the organisation has secured a £40K COVID-19 grant from the Cambridgeshire Capital Grant Scheme. The funding will enable Mursla to finalise ...

Laura Perin, PhD, and Stefano Da Sacco, PhD, of The Saban Research Institute of Children’s Hospital Los Angeles, investigate how diseases affect kidney cells at a molecular level. The National Institute of Diabetes and Digestive and Kidney Diseases have awarded Dr. ...

Kimera Labs, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera’s first-in-class XoGlo® isolated placental mesenchymal stem cell-based exosomes.  ...

Abstract: Creative Biolabs has updated its cost-effective and highly customized exosome engineering services covering exosome labeling, targeting and cargo loading into exosomes. Exosomes, small endosome derived lipid nanoparticles, function as important signal carriers through their transport of RNA, proteins, lipids ...

Obesity increases the release of tumour-promoting molecules from fat tissue and is associated with an increased risk of breast cancer, according to a study published in Endocrine-Related Cancer. The study found that fat tissue from people with obesity released...

Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor...

miR Scientific, LLC, a healthcare company whose purpose is to transform cancer management by providing early and highly accurate detection, characterization and monitoring of disease, today announced the publication of validation data...